BioSpace News Archive

Industry Leader Brings Broad Strategic and Licensing Experience in Development and Commercial Stage Biopharmaceutical Companies

Magellan Rx Management, the full-service pharmacy benefits management division of Magellan Health, Inc. (NASDAQ:MGLN), announced the launch of MRx Predict, a new advanced analytics capability that proactively identifies patients at-risk of experiencing adverse events, and forecasts future drug cost drivers for customers.

INVOKANA® has been shown to reduce the combined risk of cardiovascular death, nonfatal myocardial infarction and nonfatal stroke in patients with type 2 diabetes and established cardiovascular disease by 18 per cent compared to placebo2

Bauer will discuss the evolving healthcare insurance market and its impact on membership medicine on Friday, Oct. 26 at 10:45 a.m

Growing body of evidence, including real-world studies, points to the clinical significance of anti-citrullinated protein antibody (ACPA) as a biomarker of poor prognosis in patients with rheumatoid arthritis (RA)

Data presented at annual American Society of Human Genetics meeting

Pursuit Vascular, Inc. today announced it will be showcasing the company’s premier ClearGuard HD cap at two nephrology conferences taking place this month.

Empowerment Zone Coalition (EZC) will focus on reclaiming youth lost to drugs and alcohol abuse

Volunteer Leaders to Receive Medal of Honor

Prohibition is over in Canada!